文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

2019冠状病毒病患者院内心脏骤停的结局:多中心回顾性队列研究

In-hospital cardiac arrest in patients with coronavirus 2019.
PubMed 文献 · Resuscitation · 2021-01-27
一句话结论COVID-19患者院内心脏骤停后自主循环恢复率22.3%、30天生存率12.3%,中心间结局差异大。

该多中心回顾性队列研究纳入美国11家学术医疗中心2020年3月1日至5月31日期间因院内心脏骤停接受心肺复苏和/或除颤且SARS-CoV-2检测阳性的成年患者,共260例。最常见初始心律为无脉性电活动(45.0%)和无收缩(44.6%)。自主循环恢复58例(22.3%),出院生存31例(11.9%),30天生存32例(12.3%)。研究期间心脏骤停量最高的两家医院与其他医院相比,自主循环恢复率(10.8% vs 64.3%)和30天生存率(5.9% vs 35.7%)均显著更低(两者p<0.001)。

要点

  • COVID-19患者院内心脏骤停后30天生存率为12.3%(32/260),出院生存率为11.9%(31/260)。
  • 自主循环恢复率为22.3%(58/260),最常见初始心律为无脉性电活动(45.0%)和无收缩(44.6%)。
  • 心脏骤停量最高的两家医院与其他医院相比,自主循环恢复率10.8% vs 64.3%、30天生存率5.9% vs 35.7%,均显著更低(p<0.001)。
  • 中心间结局差异大,可能解释既往研究中的低生存率。

适用人群与场景

  • 美国11家学术医疗中心成年患者,2020年3月1日至5月31日期间因院内心脏骤停接受心肺复苏和/或除颤,且SARS-CoV-2检测阳性。

研究设计与关键结果

  • 多中心回顾性队列研究,纳入美国11家学术医疗中心260例COVID-19患者院内心脏骤停。
  • 中位年龄69岁(四分位距60-77),男性71.5%,白人49.6%,黑人16.9%,西班牙裔16.2%。
  • 最常见初始心律为无脉性电活动(45.0%)和无收缩(44.6%)。
  • 自主循环恢复58例(22.3%),出院生存31例(11.9%),30天生存32例(12.3%)。
  • 心脏骤停量最高的两家医院与其他医院相比,自主循环恢复率10.8% vs 64.3%、30天生存率5.9% vs 35.7%,均显著更低(p<0.001)。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Coronavirus Disease 2019 (COVID-19) has caused over 1 200 000 deaths worldwide as of November 2020. However, little is known about the clinical outcomes among hospitalized patients with active COVID-19 after in-hospital cardiac arrest (IHCA).

AIM: We aimed to characterize outcomes from IHCA in patients with COVID-19 and to identify patient- and hospital-level variables associated with 30-day survival.

METHODS: We conducted a multicentre retrospective cohort study across 11 academic medical centres in the U.S. Adult patients who received cardiopulmonary resuscitation and/or defibrillation for IHCA between March 1, 2020 and May 31, 2020 who had a documented positive test for Severe Acute Respiratory Syndrome Coronavirus 2 were included. The primary outcome was 30-day survival after IHCA.

RESULTS: There were 260 IHCAs among COVID-19 patients during the study period. The median age was 69 years (interquartile range 60-77), 71.5% were male, 49.6% were White, 16.9% were Black, and 16.2% were Hispanic. The most common presenting rhythms were pulseless electrical activity (45.0%) and asystole (44.6%). ROSC occurred in 58 patients (22.3%), 31 (11.9%) survived to hospital discharge, and 32 (12.3%) survived to 30 days. Rates of ROSC and 30-day survival in the two hospitals with the highest volume of IHCA over the study period compared to the remaining hospitals were considerably lower (10.8% vs. 64.3% and 5.9% vs. 35.7% respectively, p < 0.001 for both).

CONCLUSIONS: We found rates of ROSC and 30-day survival of 22.3% and 12.3% respectively. There were large variations in centre-level outcomes, which may explain the poor survival in prior studies.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Mitchell OJL, Yuriditsky E, Johnson NJ, et al. In-hospital cardiac arrest in patients with coronavirus 2019. Resuscitation. 2021. PMID: 33515638. doi:10.1016/j.resuscitation.2021.01.012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。